Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation
Nishi Kothari, Richard Kim, Robert N Jorissen, Jayesh Desai, Jeanne Tie, Hui-Li Wong, Ian Farragher, Ian Jones, Fiona L Day, Shan Li, Anuratha Sakthinandeswaren, Michelle Palmieri, Lara Lipton, Michael Schell, Jamie K Teer, David Shibata, Timothy Yeatman, Oliver M Sieber, Peter Gibbs, Ben Tran
Acta Oncologica | TAYLOR & FRANCIS LTD | Published : 2015
Awarded by National Institutes of Health under the Biostatistics and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute
We thank the Victorian Cancer BioBank for patient specimens (Australia). We also thank Total Cancer Care (R) enabled, in part, by the generous support of the DeBartolo Family, and we thank the many patients who so graciously provided data and tissue to the Total Cancer Care Consortium (United States). This work was originally presented at the 2014 Gastrointestinal Cancers Symposium. This work was supported by funding from Ludwig Cancer Research (to OMS, PG) and a NHMRC R.D. Wright Biomedical Career Development Fellowship (to OMS). This work was also supported by the National Institutes of Health [grant P30-CA76292] under the Biostatistics and Cancer Informatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute.